Chongqing Pharscin Pharmaceutical Co., Ltd. (SHE:002907)

China flag China · Delayed Price · Currency is CNY
12.76
-0.19 (-1.47%)
May 20, 2026, 1:55 PM CST
Market Cap5.41B -0.7%
Revenue (ttm)800.05M +1.9%
Net Income57.52M -25.0%
EPS0.14 -25.0%
Shares Out417.60M
PE Ratio93.99
Forward PEn/a
Dividend0.08 (0.58%)
Ex-Dividend Daten/a
Volume1,278,800
Average Volume2,772,962
Open12.95
Previous Close12.95
Day's Range12.72 - 12.95
52-Week Range12.72 - 22.69
Beta-0.09
RSI30.59
Earnings DateApr 24, 2026

About SHE:002907

Chongqing Pharscin Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of drugs in China. The company offers tablets, powders, granules, soft capsules, powder injections, freeze-dried powders, injections, chemical raw materials, and small volume injections. It provides its products for the treatment of CNS, digestion, otolaryngology, oncology, cardiovascular, and cerebrovascular related diseases. Chongqing Pharscin Pharmaceutical Co., Ltd. was founded in 1996 and is headquartered in Chongqing, China. [Read more]

Sector Healthcare
Founded 1996
Employees 1,439
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002907
Full Company Profile

Financial Performance

In 2025, SHE:002907's revenue was 827.14 million, an increase of 6.75% compared to the previous year's 774.82 million. Earnings were 65.09 million, a decrease of -15.17%.

Financial Statements